Volume 102, Issue 6
  • ISSN: 0002-9637
  • E-ISSN: 1476-1645

There is no abstract available for this article.

[open-access] This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.


Article metrics loading...

The graphs shown below represent data from March 2017
Loading full text...

Full text loading...



  1. Prompetchara E, Ketloy C, Palaga T, 2020. Immune responses in COVID-19 and potential vaccines: lessons learned from SARS and MERS epidemic. Asian Pac J Allergy Immunol 38: 19.
    [Google Scholar]
  2. de Wit E, Feldmann F, Cronin J, Jordan R, Okumura A, Thomas T, Scott D, Cihlar T, Feldmann H, 2020. Prophylactic and therapeutic remdesivir (GS-5734) treatment in the rhesus macaque model of MERS-CoV infection. Proc Natl Acad Sci USA 117: 67716776.
    [Google Scholar]
  3. Casadevall A, Pirofski LA, 2020. The convalescent sera option for containing COVID-19. J Clin Invest 130: 15451548.
    [Google Scholar]
  4. Mair-Jenkins J, Saavedra-Campos M, Baillie JK, Cleary P, Khaw FM, Lim WS, Makki S, Rooney KD, Nguyen-Van-Tam JS, Beck CR, 2015. The effectiveness of convalescent plasma and hyperimmune immunoglobulin for the treatment of severe acute respiratory infections of viral etiology: a systematic review and exploratory meta-analysis. J Infect Dis 211: 8090.
    [Google Scholar]
  5. Young MK, Nimmo GR, Cripps AW, Jones MA, 2014. Post-exposure passive immunisation for preventing measles. Cochrane Database Syst Rev 1(4): CD010056.
    [Google Scholar]
  6. Janeway CA, 1945. Use of concentrated human serum gamma-globulin in the prevention and attenuation of measles. Bull N Y Acad Med 21: 202222.
    [Google Scholar]
  7. Rinaldo CR Jr., 2005. Passive immunization against poliomyelitis: the Hammon gamma globulin field trials, 1951–1953. Am J Public Health 95: 790799.
    [Google Scholar]
  8. Krugman S, Ward R, 1961. Infectious hepatitis: current status of prevention with gamma globulin. Yale J Biol Med 34: 329339.
    [Google Scholar]
  9. Wan Y et al., 2020. Molecular mechanism for antibody-dependent enhancement of coronavirus entry. J Virol 2020 Feb 14; 94(5). pii: e02015-19.
    [Google Scholar]
  10. Shanmugaraj B, Siriwattananon K, Wangkanont K, Phoolcharoen W, 2020. Perspectives on monoclonal antibody therapy as potential therapeutic intervention for Coronavirus disease-19 (COVID-19). Asian Pac J Allergy Immunol 38: 1018.
    [Google Scholar]
  • Received : 30 Mar 2020
  • Accepted : 03 Apr 2020
  • Published online : 08 Apr 2020
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error